Massive upper gastrointestinal bleeding from Dieulafoy's lesion in the gastrointestinal tract is uncommon. The use of the Sengstaken-Blakemore tube in acute gastrointestinal bleeding has become less common since endoscopic sclerotherapy and banding procedures have become widely available. The successful use of a Sengstaken-Blakemore tube to control acute massive upper gastrointestinal bleeding from a Dieulafoy's lesion in the lower oesophagus in an elderly man with severe coronary artery disease and heart failure is described.
There are many causes of massive upper gastrointestinal bleeding. The most common causes are gastroduodenal ulcer and gastro-oesophageal variceal bleeding from portal hypertension. Dieulafoy's lesion is responsible for 2 to 7% of all significant upper gastrointestinal bleeding 1 . The successful use of a Sengstaken-Blakemore tube to control massive upper gastrointestinal bleeding from a Dieulafoy's lesion in the lower oesophagus after failed endoscopic intervention is described.
CASE HISTORY
A 71-year-old man with atrial fibrillation, severe congestive heart failure and triple vessel coronary artery disease presented to the emergency department after two episodes of haematemesis. He had been treated with aspirin, frusemide, digoxin, and warfarin while waiting for an elective coronary artery grafting procedure before this hospital admission. The left ventricle was very dilated with severe mitral regurgitation and an ejection fraction of 40% when assessed by echocardiography three months before this hospital admission. There was no history of liver disease or gastrointestinal bleeding.
He was haemodynamically stable at admission to the emergency department with a haemoglobin of 119 g/l and INR 2.7. The aPTT was normal. He was treated with intravenous omeprazole, 10 mg vitamin K and three units of fresh frozen plasma (FFP) to reverse the effect of warfarin. The haemoglobin dropped to 88 g/l four hours after hospital admission and blood transfusion was started. Urgent upper gastrointestinal endoscopy was performed eight hours after hospital admission. He had a total of five units of blood before the endoscopy. The haemoglobin after five units of blood was 111 g/l but the platelet count had dropped to 34,000/mm 3 . The INR was normalized after three units of FFP. Endoscopy showed active arterial bleeding from a small protruding vessel in the lower end of the oesophagus where the mucosa appeared normal ( Figure 1 ). The endoscopic features were compatible with a Dieulafoy's lesion in the lower end of the oesophagus. The stomach and the duodenum were unremarkable. Haemostasis was temporarily achieved by adrenaline injection and bipolar diathermy through the endoscope. He was admitted to the Intensive Care Unit (ICU) for further management.
In the ICU, the patient was treated with oral sucralfate, intravenous omeprazole infusion (8 mg/h), octreotide infusion (50 µg/h), and a ten unit platelet transfusion. Arterial and central venous lines were inserted to facilitate monitoring and vascular access. He remained haemodynamically stable in the first six hours after ICU admission and the platelet count increased to 130,000/mm 3 . About seven hours after ICU admission, the patient suddenly developed severe hypotension with a systolic blood pressure of 60 mmHg. There was no haematemesis. The blood pressure was restored after rapid infusion of 1000 ml of Gelofusine ® (succinylated gelatin solution 4%, B. Braun New Zealand) and the repeat haemoglobin was 85 g/l. Three units of blood were transfused urgently, and the endoscopist and the surgeon were consulted. The endoscopist was unwilling to repeat any endoscopic intervention because of the high risk of oesophageal perforation. The surgeon was prepared to operate but preferred alternative treatment if possible because of the patient's severe heart disease and the operative risk. The clinical decision at the time was to try a Sengstaken-Blakemore tube and to proceed to surgery or angiographic embolization if the Sengstaken-Blakemore tube failed to stop the bleeding.
After anaesthesia was induced and the airway secured, a Sengstaken-Blakemore tube was inserted orally with the assistance of direct laryngoscopy and Magill forceps. After confirming the tip of the Sengstaken-Blakemore tube was in the stomach by free aspiration of gastric content and auscultation, 200 ml of normal saline was injected into the gastric balloon slowly. The proximal end of the tube was fixed to the patient's face by adhesive tape to maintain mild traction on the tube. Approximately 40 ml of air was then injected into the oesophageal balloon to achieve a pressure of 25 to 30 cmH 2 O as measured by a pressure manometer. After the Sengstaken-Blakemore tube was inserted, there was no obvious clinical bleeding as observed from the gastric lumen aspirate and the haemoglobin remained stable for 10 hours without transfusion. The usual practice of the ICU is to deflate both balloons at regular intervals of 8 to 10 hours and not to leave the Sengstaken-Blakemore tube in the patient longer than 24 to 48 hours. In our patient, both balloons of the Sengstaken-Blakemore tube were deflated 10 hours after insertion but the tube was left in situ for a total of 24 hours while the patient was sedated and ventilated. Repeat endoscopy after removing the Sengstaken-Blakemore tube showed a large blood clot around the cardia of the stomach but no obvious source of bleeding could be identified. The patient remained haemodynamically stable and was extubated 72 hours later without evidence of myocardial infarction during his stay in the ICU.
DISCUSSION
Dieulafoy's lesion is an uncommon cause of upper gastrointestinal bleeding 1, 2 . It consists of a submucosal arteriole that breaks through the mucosa for reasons that are unknown, usually within 6 cm of the gastrointestinal junction on the lesser curve of the stomach 2,3 . Dieulafoy's lesion has also been reported in the lower oesophagus 4 , duodenum 5 , jejunum, colon and rectum 2 . The diagnosis is often difficult because bleeding is usually massive and the bleeding site is not associated with any obvious ulcer that can facilitate localization of the lesion. Less than 50% of the lesions are identified during the initial endoscopic examination although repeated endoscopy will improve the diagnostic yield, especially when there is active bleeding 2 . The endoscopic criteria proposed to define Dieulafoy's lesion are 1) active arterial bleeding from a minute mucosal defect or through normal surrounding muscoa, 2) visualization of a protruding vessel with or without active bleeding within a minute mucosal defect or through normal surrounding mucosa, and 3) fresh densely adherent clot with a narrow point of attachment to a minute mucosal defect or to normal appearing mucosa 5 . Before urgent endoscopy was widely available, Dieulafoy's lesion was usually diagnosed by angiography or at surgery 6, 7 .
The treatment of Dieulafoy's lesion consists of endoscopic haemoclip placement 1 , endoscopic injection therapy followed by thermal ablation 3 , surgery 4 , or angiographic embolization 8 . Endoscopic therapy is reported to be successful in achieving permanent haemostasis in 85% of cases 2 . Surgery carries a mortality rate of 25% in those patients who rebleed 9 . Angiographic embolization has been suggested to be an alternative in patients who are not amenable to endoscopic therapy and are poor surgical candidates, although comprehensive data in the success rate of this therapy is scarce 2, 8 . The perioperative risk in our patient was regarded as very high with his history of severe coronary artery disease and congestive heart failure. The use of the Sengstaken-Blakemore tube to control gastrointestinal bleeding from Dieulafoy's lesion in the lower oesophagus in such a high risk patient has not been described before. In our patient, the bleeding was controlled by the use of the Sengstaken-Blakemore tube and a major operation was avoided.
The Sengstaken-Blakemore tube was used commonly to control gastric or oesophageal variceal bleeding before endoscopic procedures such as banding and injection sclerotherapy were available. However, the Sengstaken-Blakemore tube does not provide any diagnostic information about the cause of the gastrointestinal bleeding and is of no use in the bulk of bleeding sites. It is now regarded as a second or third line treatment for acute variceal bleeding because of its potential complications and a lower success rate when compared with endoscopic procedures 10 . Before considering the use of a Sengstaken-Blakemore tube for any gastrointestinal bleeding, the exact cause of the bleeding should be identified and the location of bleeding should be confirmed to be close to the gastroesophageal junction. Secondly, the risks and benefits of inserting a Sengstaken-Blakemore tube must be thoroughly considered and balanced against alternative therapy such as angiographic embolization or surgery for different individual patients.
The complications of a Sengstaken-Blakemore tube can be serious and life-threatening. They include aspiration, major airway obstruction 11 , oesophageal pressure necrosis with prolonged inflation, rupture of oesophagus 12 , jejunum 13 , and trachea 14 , innominate vein obstruction 15 , and impaction of the tube in the oesophagus 16 . In order to avoid these complications, experience in inserting the tube and the knowledge of how to avoid the potential complications is a prerequisite for its use 18 . The patient's airway should be protected by an endotracheal tube, and by doing so it will also facilitate insertion of a Sengstaken-Blakemore tube orally under direct vision with a direct laryngoscopy. The oral route has the advantage of avoiding pressure necrosis on the nares. Before inflating the gastric balloon, the correct positioning of the tube in the stomach must be confirmed by aspiration of gastric contents, auscultation, and sometimes X-ray in difficult cases. Inflating the gastric balloon with 200 ml of normal saline is preferable as a smaller volume may increase the risk of herniation of the gastric balloon into the oesophagus when traction is applied 11 . For the same reason, we do not recommend any external weight traction on the Sengstaken-Blakemore tube other than securing the proximal end of the tube on patient's face with strong adhesive tape. The oesophageal balloon pressure should be monitored regularly and kept below 45 mmHg. Both gastric and oesophageal balloons should also be deflated regularly to avoid pressure necrosis on the oesophagus and stomach. Finally, the Sengstaken-Blakemore tube should be removed as soon as the bleeding is under control and in general not longer than 24 to 48 hours to reduce the risk of complications.
Apart from acute variceal bleeding, the Sengstaken-Blakemore tube has also been reported as a useful alternative therapy in controlling postpartum bleeding 18 , aorto-oesophageal fistula bleeding 19, 20 and silastic ring vertical gastroplasty bleeding 21 .
In conclusion, the Sengstaken-Blakemore tube can be considered as an alternative or temporary treatment to control massive upper gastrointestinal bleeding from Dieulafoy's lesion in the lower oesophagus when endoscopic intervention is not successful. The complications of insertion of a Sengstaken-Blakemore tube are not uncommon. The use of a Sengstaken-Blakemore tube is indicated only when endoscopic therapy is not successful and its benefits outweigh the risks in patients who have severe comorbidity and high operative risk.
